In Inflammatory Myopathies, Dropped Head/bent Spine Syndrome is Associated with Scleromyositis: an International Case-control Study

Background: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM).

Objectives: To assess the significance of DH/BS in patients with IM.

Methods: Practitioners from five IM networks were invited to report patients with IM suffering from DH/BS (without other known cause than IM). IM patients without DH/BS, randomly selected in each participating centre, were included as controls at a ratio of 2 to 1.

Results: 49 DH/BS-IM patients (DH: 57.1%, BS: 42.9%) were compared with 98 control-IM patients. DH/BS-IM patients were older (65 years vs 53 years, p<0.0001) and the diagnosis of IM was delayed (6 months vs 3 months, p=0.009). Weakness prevailing in the upper limbs (42.9% vs 15.3%), dysphagia (57.1% vs 25.5%), muscle atrophy (65.3% vs 34.7%), weight loss (61.2% vs 23.5%) and loss of the ability to walk (24.5% vs 5.1%) were hallmarks of DH/BS-IM (p≤0.0005), for which the patients more frequently received intravenous immunoglobulins (65.3% vs 34.7%, p=0.0004). Moreover, DH/BS-IM patients frequently featured signs and/or complications of systemic sclerosis (SSc), fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for this disease in 40.8% of the cases (vs 5.1%, p<0.0001). Distribution of the myopathy, its severity and its association with SSc were independently associated with DH/BS (p<0.05). Mortality was higher in the DH/BS-IM patients and loss of walking ability was independently associated with survival (p<0.05).

Conclusion: In IM patients, DH/BS is a marker of severity and is associated with SSc (scleromyositis).

Citing Articles

Case report: A patient with brachio-cervical inflammatory myopathy was misdiagnosed as flail arm syndrome.

Sun H, Wei X, Han Y, Wang Y, Wang Z, Yu X Front Immunol. 2024; 15:1378130.

PMID: 39021570 PMC: 11251991. DOI: 10.3389/fimmu.2024.1378130.

Systemic sclerosis associated myopathy: how to treat.

Selva-OCallaghan A, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguas E, Matas-Garcia A, Milisenda J Curr Treatm Opt Rheumatol. 2024; 9(4):151-167.

PMID: 38737329 PMC: 11086655. DOI: 10.1007/s40674-023-00206-y.

References

Lloyd T, Mammen A, Amato A, Weiss M, Needham M, Greenberg S . Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology. 2014; 83(5):426-33. PMC: 4132572. DOI: 10.1212/WNL.0000000000000642. View

De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C . Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. Neurology. 2018; 90(23):e2068-e2076. PMC: 5993182. DOI: 10.1212/WNL.0000000000005638. View

Meyer A, Scire C, Talarico R, Alexander T, Amoura Z, Avcin T . Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected]. RMD Open. 2019; 4(Suppl 1):e000784. PMC: 6397434. DOI: 10.1136/rmdopen-2018-000784. View

Ghosh P, Milone M . Camptocormia as presenting manifestation of a spectrum of myopathic disorders. Muscle Nerve. 2015; 52(6):1008-12. DOI: 10.1002/mus.24689. View

Ellezam B, Leclair V, Troyanov Y, Meyer A, Hudson M, Landon-Cardinal O . Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'. Acta Neuropathol. 2021; 142(2):395-397. DOI: 10.1007/s00401-021-02335-x. View

Meyer A, Lannes B, Goetz J, Echaniz-Laguna A, Lipsker D, Arnaud L . Inflammatory myopathies: A new landscape. Joint Bone Spine. 2017; 85(1):23-33. DOI: 10.1016/j.jbspin.2017.03.005. View

Lynch B, Stern E, Ong V, Harber M, Burns A, Denton C . UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis. Clin Exp Rheumatol. 2016; 34 Suppl 100(5):106-109. View

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

Alhammad R, Naddaf E . Myopathies presenting with head drop: Clinical spectrum and treatment outcomes. Neuromuscul Disord. 2020; 30(2):128-136. DOI: 10.1016/j.nmd.2019.12.001. View

10.

Mammen A, Allenbach Y, Stenzel W, Benveniste O . 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018. Neuromuscul Disord. 2019; 30(1):70-92. DOI: 10.1016/j.nmd.2019.10.005. View

11.

Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F . Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurol. 2018; 75(12):1528-1537. PMC: 6583199. DOI: 10.1001/jamaneurol.2018.2598. View

12.

van den Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A . 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72(11):1747-55. DOI: 10.1136/annrheumdis-2013-204424. View

13.

Allenbach Y, Mammen A, Benveniste O, Stenzel W . 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2017; 28(1):87-99. DOI: 10.1016/j.nmd.2017.09.016. View

14.

Giannini M, Ellezam B, Leclair V, Lefebvre F, Troyanov Y, Hudson M . Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis. Front Immunol. 2023; 13:974078. PMC: 9910219. DOI: 10.3389/fimmu.2022.974078. View

15.

Rider L, Giannini E, Brunner H, Ruperto N, James-Newton L, Reed A . International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum. 2004; 50(7):2281-90. DOI: 10.1002/art.20349. View

16.

Ali F, Matsumoto J, Hassan A . Camptocormia: Etiology, diagnosis, and treatment response. Neurol Clin Pract. 2018; 8(3):240-248. PMC: 6075991. DOI: 10.1212/CPJ.0000000000000453. View

17.

Lundberg I, Tjarnlund A, Bottai M, Werth V, Pilkington C, de Visser M . 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017; 76(12):1955-1964. PMC: 5736307. DOI: 10.1136/annrheumdis-2017-211468. View

18.

Butler E, Baron M, Fogo A, Frech T, Ghossein C, Hachulla E . Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis Rheumatol. 2019; 71(6):964-971. DOI: 10.1002/art.40809. View

19.

Ellezam B, Leclair V, Troyanov Y, Bersali I, Giannini M, Hoa S . Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis. Neuropathol Appl Neurobiol. 2022; 48(7):e12840. DOI: 10.1111/nan.12840. View

20.

Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper R, New R . Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun. 2019; 101:48-55. PMC: 6580360. DOI: 10.1016/j.jaut.2019.04.001. View